FDA Investigator Nicholas J Scire
Nicholas J Scire has conducted inspections on 59 sites in 1 countries as of 08 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
59
Last Inspection Date:
08 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Nicholas J Scire:
Aaron L Morris,
Affiong Flores,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Alyssa R Favro,
Anne E Carpenter,
Bradford L Swanson,
Brandy L Couillard,
Brenna L Macdowell,
Brian P Hendrickson,
Carl A Huffman, III,
Christine M Malone,
Christopher J Cruciotti,
Christopher M Elliott,
Clinton V Giustra,
Cullen T Wilson,
Dana A Razzano,
David S Firley,
Dean R Rugnetta,
Diamond M Oden,
Diantha M Bleau,
Diantha M Turner,
Donna J Clevenger,
Douglas S Joslin,
Edmund F Mrak, Jr,
Emily J Schramm,
Erich P Garger,
Frank J Koch,
Garry H Stewart,
Gordon R Davidson,
Greg W Hites,
Isaac K Carney,
James K Mcnally,
Janis S Gallagher,
Jay M Patria,
John A Hollings,
John P Shelton,
John S Hartford,
Joseph Foley,
Joseph T Frost,
Joyce A Kellett,
Kleever N Soto Santiago,
Lauren M Lawrance,
Laurie B Frazier,
Lorayne A Mcguinness,
Lori A Holmquist,
Louis Christy,
Lyndsay M Perryman,
Mark E Farrell,
Maryam Tabatabaie,
Mecado,
Michael P Mcpartlin,
Mikayla K Deardorff,
Nasser Yazdani, DVM, MPH,
Nichole B Murphy,
Osama A Khatib,
Rebecca A Coleman,
Rebecca L Vigue,
Richard F Hapke,
Richard G Fochesato,
Richard W Skodinski,
Robert D Ogan,
Robert E Teel,
Rupa Pradhan,
Scott M Loughan,
Sean M Tessicini,
Shawn M Bogdan,
Slater K Bartlett,
Tania K Mercado,
Terry C Kimball,
Thomas Cote,
Thomas H Jenkins,
Thomas O Morgan,
Thomas Siebertz,
Torrance J Slayton,
Troy R Petrillo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more